Jiangsu Key Laboratory of Biofunctional Materials, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210046, People's Republic of China.
J Mater Sci Mater Med. 2012 Jul;23(7):1629-35. doi: 10.1007/s10856-012-4656-9. Epub 2012 May 3.
Nanoparticles of a hydrophobic photosensitizer, tetrakis (3-trifluoromethylphenoxy) zinc phthalocyanine (FPcZn) have been synthesized by using a simple reprecipitation technique. The resulting drug nanoparticles (FPcZn-NP) were spherical, highly monodispersed and stable in aqueous system, without an additional stabilizer. Comparative studies with FPcZn-NP and FPcZn indicated that after the formation of nanoparticles, FPcZn-NP maintained the efficiency of (1)O(2) generation. Further more, the in vitro studies demonstrated that such nanoparticles can be efficiently taken up by Hela cells, which might be resulted to cell death by light irradiation. These properties could make the FPcZn-NP to be a promising candidate in clinical photodynamic therapy.
疏水型光敏剂四(3-三氟甲氧基苯氧基)锌酞菁(FPcZn)的纳米粒子已通过简单的再沉淀技术合成。所得药物纳米粒子(FPcZn-NP)为球形,高度单分散且在水体系中稳定,无需添加额外的稳定剂。与 FPcZn-NP 和 FPcZn 的对比研究表明,纳米粒子形成后,FPcZn-NP 仍能保持(1)O(2)的生成效率。此外,体外研究表明,此类纳米粒子可被 Hela 细胞有效摄取,这可能导致光照下的细胞死亡。这些特性使 FPcZn-NP 成为临床光动力治疗的一种有前途的候选药物。